CRISPR-modified human iPSC-microglia respond to
Author: Michael
Coya’s biologic therapeutic aims to suppress c
Metabolic feature of mutant stem cells offers a
New initiative to drive advancements in longevit
New data from a 12-week trial indicate that trea
Seveno Capital makes first investment and launch
Elevate Chief Medical Officer Nitin Shori on why
New Manulife-WEF initiative aims to ‘move the
Company targets Phase 2 trial of MKK4 inhibitor
Aubrey de Grey and James Strole look ahead to RA